HSCS
HSCS
NASDAQ · Health Care

Heartsciences Inc

$2.19
-0.07 (-3.10%)
Financial Highlights (FY 2026)
Revenue
8.0K
Net Income
-17,303,539
Gross Margin
59.0%
Profit Margin
-211,617.6%
Rev Growth
-6.0%
D/E Ratio
16.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.0% 59.0% 46.4% 46.4%
Operating Margin -194,742.4% -175,279.4% 16.1% 16.8%
Profit Margin -211,617.6% -201,036.7% 17.0% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 8.0K 8.5K 3.30M 3.40M
Gross Profit 4.7K 5.0K 1.53M 1.58M
Operating Income -15,482,017 -14,821,630 530.1K 570.8K
Net Income -17,303,539 -16,565,455 560.2K 453.4K
Gross Margin 59.0% 59.0% 46.4% 46.4%
Operating Margin -194,742.4% -175,279.4% 16.1% 16.8%
Profit Margin -211,617.6% -201,036.7% 17.0% 13.3%
Rev Growth -6.0% -6.0% +13.2% +5.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 6.62M 6.62M 3.60M 4.54M
Total Equity 413.1K 413.1K 4.32M 3.69M
D/E Ratio 16.02 16.02 0.83 1.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -15,870,895 -16,038,028 944.9K 908.1K
Free Cash Flow — — 381.1K 454.7K